Drug Shortage Report for OZURDEX
Report ID | 80819 |
Drug Identification Number | 02363445 |
Brand name | OZURDEX |
Common or Proper name | dexamethasone intravitreal implant |
Company Name | ABBVIE CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | DEXAMETHASONE |
Strength(s) | 0.7MG |
Dosage form(s) | IMPLANT |
Route of administration | INTRAVITREAL |
Packaging size | 1 implant |
ATC code | S01BA |
ATC description | ANTIINFLAMMATORY AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-04-15 |
Actual start date | |
Estimated end date | 2019-04-30 |
Actual end date | 2019-04-26 |
Shortage status | Resolved |
Updated date | 2019-04-27 |
Company comments | Rebuilding in country inventory levels following prior supply disruption. Resupply in late April will be sufficient quantity to meet ongoing customer & patient demand. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 8401 TRANS-CANADA HIGHWAY SAINT-LAURENT, QUEBEC CANADA H4S 1Z1 |
Company contact information | Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-04-08 | English | Compare |
v2 | 2019-04-08 | English | Compare |
v3 | 2019-04-08 | French | Compare |
v4 | 2019-04-16 | English | Compare |
v5 | 2019-04-26 | English | Compare |
v6 | 2019-04-26 | French | Compare |
v7 | 2019-04-27 | English | Compare |
Showing 1 to 7 of 7